Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Roche reports new adenosine A2A receptor ligands and use for Parkinson's, depression

Feb. 3, 2005

New antiinfective agents from Dr. Reddy's

Feb. 3, 2005

Guilford discloses new PARP inhibitors

Feb. 2, 2005

Calcium channel blockers emerge from NeuroMed R&D

Feb. 2, 2005

Integrin antagonists in early development at Genentech

Feb. 2, 2005

OSI scientists develop new glycogen phosphorylase inhibitors

Feb. 2, 2005

Ajinomoto patents TRPV receptor ligands for treatment of pain

Feb. 2, 2005

New compounds for immune-mediated diseases designed at Merck

Feb. 2, 2005

5HT-7 receptor modulators and their use in IBS claimed by Ajinomoto

Feb. 1, 2005

New DPP-IV inhibitors discovered at Syrrx

Feb. 1, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...